Bioorganic & Medicinal Chemistry 2018-04-10

Development of concise two-step catalytic approach towards lasofoxifene precursor nafoxidine

Carin C.C. Johansson Seechurn, Ivana Gazić Smilović, Thomas Colacot, Antonio Zanotti-Gerosa, Zdenko Časar

Index: 10.1016/j.bmc.2018.04.021

Full Text: HTML

Abstract

We have elaborated a two-step catalytic approach to nafoxidine, a key precursor to lasofoxifene. Firstly, an efficient α-arylation of 6-methoxy-3,4-dihydronaphthalen-1(2H)-one with chlorobenzene was developed, which operates at low 0.1 mol% Pd-132 catalyst loading in the presence of 1.9 equivalents of sodium tert-butoxide at 60 °C in 1,4-dioxane and provides 6-methoxy-2-phenyl-3,4-dihydronaphthalen-1(2H)-one in 90% yield. Secondly, we have demonstrated that 6-methoxy-2-phenyl-3,4-dihydronaphthalen-1(2H)-one can be converted to nafoxidine in 61% yield via CeCl3 promoted reaction with (4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)lithium, which is formed in-situ from the corresponding arylbromide precursor and n-butyllithium. Altogether, the shortest two-step approach to nafoxidine from simple tetralone commodity starting material has been developed with overall 55% yield. The developed synthetic approach to nafoxidine has several beneficial aspects over the one used in the synthetic route primarily developed for the preparation of lasofoxifene.

Latest Articles:

Substituent effect of N-benzylated gramine derivatives that prevent the PP2A inhibition and dissipate the neuronal Ca2+ overload, as a multitarget strategy for the treatment of Alzheimer’s disease

2018-04-09

[10.1016/j.bmc.2018.04.019]

Rational Design and Screening of Peptide-Based Inhibitors of Heat Shock Factor 1 (HSF1)

2018-04-07

[10.1016/j.bmc.2018.04.018]

Characterization of Protease-Activated Receptor (PAR) ligands: Parmodulins are reversible allosteric inhibitors of PAR1-driven calcium mobilization in endothelial cells

2018-04-06

[10.1016/j.bmc.2018.04.016]

Screening of ligands for redox-active europium using magnetic resonance imaging

2018-04-04

[10.1016/j.bmc.2018.04.001]

Site-Specific Incorporation of Quadricyclane into a Protein and Photocleavage of the Quadricyclane Ligation Adduct

2018-04-04

[10.1016/j.bmc.2018.04.009]

More Articles...